Omeprazole/amoxicillin/rifabutin

Omeprazole/amoxicillin/rifabutin, sold under the brand name Talicia, is a fixed-dose combination medication used for the treatment of Helicobacter pylori infection.[1] It is taken by mouth.[1]

Omeprazole/amoxicillin/rifabutin
Combination of
OmeprazoleProton-pump inhibitor
AmoxicillinPenicillin-class antibacterial
RifabutinRifamycin antibacterial
Clinical data
Trade namesTalicia
AHFS/Drugs.comProfessional Drug Facts
License data
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

It was approved for medical use in the United States in November 2019.[2]

References

edit
  1. ^ a b c "Talicia- omeprazole magnesium, amoxicillin and rifabutin capsule, delayed release". DailyMed. Retrieved 4 October 2021.
  2. ^ "Drug Approval Package: Talicia". U.S. Food and Drug Administration (FDA). 9 April 2020. Retrieved 4 October 2021.
edit
  • "Omeprazole". Drug Information Portal. U.S. National Library of Medicine.
  • "Amoxicillin". Drug Information Portal. U.S. National Library of Medicine.
  • "Rifabutin". Drug Information Portal. U.S. National Library of Medicine.
  • Clinical trial number NCT03198507 for "ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator (ERADICATE Hp2)" at ClinicalTrials.gov
  • Clinical trial number NCT01980095 for "ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 (ERADICATE Hp)" at ClinicalTrials.gov